ReviewInternational journal of impotence research2026
E-cigarettes and erectile dysfunction: biological mechanisms and research challenges.
Review in International journal of impotence research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electronic cigarettes are widely promoted as harm-reduction alternatives to conventional tobacco smoking, yet their potential effects on male sexual health remain incompletely characterised. Erectile dysfunction is a predominantly vascular condition with important neuroendocrine regulation and is highly sensitive to endothelial injury, oxidative stress, hormonal imbalance, and autonomic dysregulation, all of which may plausibly be influenced by electronic cigarette use. Despite increasing global prevalence, direct evidence linking electronic cigarette use to erectile dysfunction remains limited. This narrative review synthesises current experimental, clinical, and epidemiological evidence examining the association between electronic cigarette use and erectile dysfunction, with emphasis on underlying biological mechanisms and key research gaps. Emerging evidence implicates endothelial dysfunction, impaired nitric oxide bioavailability, oxidative stress, inflammation, hormonal disturbance, autonomic imbalance, sleep disturbance, and exposure to aerosolised substances and metals as interconnected pathways that may contribute to erectile dysfunction. Overall, the existing literature remains preliminary and largely hypothesis-generating, with no longitudinal studies capable of establishing causality or dose-response relationships. Well-designed prospective studies are required to clarify the long-term sexual health outcomes associated with electronic cigarette use.
Identifiers
42298128What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.